Health
SRI has been a leader for decades in the development of tools, technologies, and therapeutics that have saved and improved countless lives around the world. Our Biosciences division works with government and commercial clients to seamlessly integrate basic and translational research, drug discovery, and nonclinical and clinical development.
-
Scientists at SRI International have developed a peptide that targets lung tumors and delivers therapeutics inside the cells
The newly optimized molecular vehicle provides effective, targeted delivery of anticancer agents to lung tumors.
-
SRI International appoints Kathlynn Brown to Biosciences Division President
The SRI International veteran to expand leadership for the innovations needed to cure diseases and improve people’s health.
-
Women participants needed for NIH funded research study on memory and sleep
We are looking for healthy women to participate in an NIH funded research study exploring the impact of sex hormones on memory and sleep.
-
SRI International celebrates global recognition of Bioinformatics Research Group and its BioCyc and Pathway Tools collection
SRI’s BioCyc and Pathway Tools publication contributors named to 2022 Highly Cited Researchers List; EcoCyc selected as Global Core Biodata Resource.
-
Menopause goes high tech: Understanding your menopause journey by leveraging AI and wearable sensing technology
SRI spinout Lisa Health tackles the menopause gap with AI, digital therapeutics and a new app.
-
Health, wellbeing and community innovations for a better planet
Spotlighting impactful studies and solutions from SRI International this World Health Day.
-
Formulating a solution to mass radiation exposure
In the event of a radiation leak or nuclear accident, oral medication options are needed for quick-turnaround, effective, large-scale treatment.
-
Intracellular delivery—now a reality for many types of therapeutics
Unlocking the therapeutic potential of antisense oglionucleotides and other biologics.
-
HOPO: Partnering to Advance Therapy for Radiation Exposure
SRI scientists collaborate with Lawrence Berkeley National Laboratory to chart a path for obtaining regulatory approval for a clinical development plan for a novel decorporation agent.
-
How SRI’s AI technology is changing the way healthcare is delivered
Governments around the world have encouraged healthcare providers to utilize Telehealth to safely care for patients
-
75 Years of Innovation: Cancer research
Innovations in treatments and mechanism of treatment delivery in the fight against cancer